The 3D cell culture market is highly competitive with several big and small players. Prominent players in this market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US.), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).

Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of this market. The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

Thermo Fisher was the leading player in the 3D cell culture market in 2016. The company’s leading position is primarily attributed to its strong brand image and product portfolio. Thermo Fisher constantly focuses on strengthening its product portfolio.

Corning was the second-largest leading player in the global 3D cell culture market in 2016. The leading position of the company is attributed to its robust product portfolio which includes scaffold-based and scaffold-free products. To maintain its strong position in the market, the company focuses on adopting organic and inorganic growth strategies such as expansions, agreements, partnerships, and collaborations.

Know more: https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html